China National Medicines Corporation Ltd.’s Net Profit Rose 13.9% in First Half of 2023

China National Medicines Corporation Ltd. (国药集团药业股份有限公司) (600511.SH) reported a net profit of 1.1 billion yuan in the first half of 2023, up 13.9% year-on-year.

Meanwhile, the company posted 24.1 billion yuan in revenue, up 9.7% year-on-year.

At the end of the reporting period, it had 30.8 billion yuan in total assets and 14.5 billion yuan in total liabilities, with a liability-to-asset ratio of 47.1%.